Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20220309054225N1
IRCT20220309054225N1
Not yet recruiting
Phase 2

Clinical trial evaluating the effects of curcumin nanoformula on TH17 and Treg cell-related markers in patients with rheumatoid arthritis and comparing it with placebo

Yazd University of Medical Sciences0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Yazd University of Medical Sciences
Enrollment
30
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Yazd University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Patients are women
  • •The age range is between 18\-65 years
  • •Measured by the European American College Rheumatology Criteria (EULAR\-ACR) by a rheumatologist
  • •Their DAS (disease activity scort28\) is between 8\.2 and 5, which is assessed by a rheumatologist.

Exclusion Criteria

  • •Refusal to give informed consent
  • •Chronic Diseases affecting ESR, CRP levels such as diabetes and heart disease
  • •Pregnancy and lactation
  • •Nervous disorders
  • •Abnormal Creatinine (greater than 1/5\)
  • •Abnormal liver enzymes (AST\-ALT) (3 times normal)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Effect of curcumin (tumeric) on patients with Metabolic syndrome
IRCT201512181165N12Baghiyatallah University of Medical Sciences100
Recruiting
Phase 2
The effects of curcumin on Attention-Deficit/Hyperactivity Disorder (ADHD) patientsAttention-Deficit/Hyperactivity Disorder (ADHD).Disturbance of activity and attention
IRCT2017050433810N1Vice Chancellor for Research, Mashhad University of Medical Sciences70
Completed
Phase 3
The effect of curcumin supplementation plus resistance training in treatment of patients with Parkinson's
IRCT20191231045968N1Kharazmi University40
Recruiting
Phase 2
The effect of Curcumin on the prevention of fatty liver caused by tamoxifeFatty liver caused by tamoxifen in patients with non-metastatic breast cancer.Malignant neoplasm of breast of unspecified site, femaleC50.91
IRCT20240501061618N1Esfahan University of Medical Sciences44
Not yet recruiting
Phase 3
Effect of curcumin on oral lichen planus
IRCT20160420027501N2Islamic Azad University28